Careful potassium monitoring is advocated in patients with lower eGFR receiving RAASi and diuretics due to the common occurrence of dyskalemia.
Supports potassium monitoring in low-eGFR patients on RAASi and diuretics; leaves open effects on outcomes from observational data.
Hypo- and hyperkalemia are common in healthcare. Optimal RAASi and diuretics use and careful potassium monitoring in the presence of certain comorbidities, especially lower eGFR, is advocated.
No takes yet. Share an insight, caveat, or question.
Nilsson et al. (2017) studied this question.